RE: Time for.....3 Jan 2025 10:49
From their RNS in March in relation to Financial, Business and Pf update. Not my words, but their very own. You can also draw your own conclusions in relation to returning investor value.
'In each of these potential deals we would expect to receive significant up-front payments on signing, with further receipts on achievement of development and/or sales milestones plus royalties on sales.
The therapeutic indications of our products will be entering markets which offer the realistic prospect of multi-billion dollar annual sales, which in turn, will be reflected in the levels of income we expect to be receiving in both the short, medium and long term.
It is this expectation which will drive the fundamental value of the Company and deliver the return on investment to our shareholders.'